380 related articles for article (PubMed ID: 28625598)
1. Predictors of Long-Term Outcomes After Drug-Eluting Balloon Angioplasty for Bare-Metal Stent Restenosis.
Hsieh MJ; Huang YC; Yeh JK; Chen CC; Chen DY; Yang CH; Tsai ML; Ho MY; Chang SH; Wang CY; Lee CH; Hsieh IC
Heart Lung Circ; 2018 May; 27(5):588-594. PubMed ID: 28625598
[TBL] [Abstract][Full Text] [Related]
2. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS
Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660
[TBL] [Abstract][Full Text] [Related]
3. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.
Belkacemi A; Agostoni P; Nathoe HM; Voskuil M; Shao C; Van Belle E; Wildbergh T; Politi L; Doevendans PA; Sangiorgi GM; Stella PR
J Am Coll Cardiol; 2012 Jun; 59(25):2327-37. PubMed ID: 22503057
[TBL] [Abstract][Full Text] [Related]
4. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
[TBL] [Abstract][Full Text] [Related]
5. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
[TBL] [Abstract][Full Text] [Related]
6. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M
Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844
[TBL] [Abstract][Full Text] [Related]
7. Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.
Habara S; Kadota K; Shimada T; Ohya M; Amano H; Izawa Y; Kubo S; Hyodo Y; Otsuru S; Hasegawa D; Tada T; Tanaka H; Fuku Y; Goto T; Mitsudo K
J Am Coll Cardiol; 2015 Jul; 66(1):14-22. PubMed ID: 26139053
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of drug-eluting balloon in patients with bare-metal or drug-eluting stent restenosis.
Berta B; Jambrik Z; Kohar K; Szabo G; Ruzsa Z; Molnar L; Barczi G; Geller L; Becker D; Merkely B
Hellenic J Cardiol; 2014; 55(5):369-77. PubMed ID: 25243435
[TBL] [Abstract][Full Text] [Related]
9. Impact of Optimized Procedure-Related Factors in Drug-Eluting Balloon Angioplasty for Treatment of In-Stent Restenosis.
Rhee TM; Lee JM; Shin ES; Hwang D; Park J; Jeon KH; Kim HL; Yang HM; Han JK; Park KW; Hahn JY; Koo BK; Kim SH; Kim HS
JACC Cardiovasc Interv; 2018 May; 11(10):969-978. PubMed ID: 29798774
[TBL] [Abstract][Full Text] [Related]
10. The Leipzig Prospective Drug-Eluting Balloon-Registry - Outcome of 484 Consecutive Patients Treated for Coronary In-Stent Restenosis and De Novo Lesions Using Paclitaxel-Coated Balloons.
Uhlemann M; Möbius-Winkler S; Adam J; Erbs S; Mangner N; Sandri M; Boudriot E; Woinke M; Schuler GC; Linke A
Circ J; 2016; 80(2):379-86. PubMed ID: 26632530
[TBL] [Abstract][Full Text] [Related]
11. Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: the nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial.
Nijhoff F; Agostoni P; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Stella PR
Catheter Cardiovasc Interv; 2015 Oct; 86 Suppl 1():S34-44. PubMed ID: 26119971
[TBL] [Abstract][Full Text] [Related]
12. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting balloon (DEB) for de-novo coronary artery disease and in-stent restenosis: immediate and intermediate term results from a prospective registry.
Ahmed W; Shah MA; Thaver AM; Mirza J
J Pak Med Assoc; 2011 Feb; 61(2):157-60. PubMed ID: 21375166
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Clinical Results Following the Use of Drug-Eluting Balloons for a Bare-Metal Stent and Drug-Eluting Stent Instent Restenosis.
Lee WC; Fang YN; Fang CY; Chen CJ; Yang CH; Yip HK; Hang CL; Wu CJ; Fang HY
J Interv Cardiol; 2016 Oct; 29(5):469-479. PubMed ID: 27501848
[TBL] [Abstract][Full Text] [Related]
15. The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment.
Stella PR; Belkacemi A; Waksman R; Stahnke S; Torguson R; von Strandmann RP; Agostoni P; Sangiorgi G; Silber S;
EuroIntervention; 2011 Oct; 7(6):705-10. PubMed ID: 21959672
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting balloon versus bare-mental stent and drug-eluting stent for de novo coronary artery disease: A systematic review and meta-analysis of 14 randomized controlled trials.
Cui K; Lyu S; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang D; Dai J
PLoS One; 2017; 12(4):e0176365. PubMed ID: 28445555
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.
Adriaenssens T; Dens J; Ughi G; Bennett J; Dubois C; Sinnaeve P; Wiyono S; Coosemans M; Belmans A; D'hooge J; Vrolix M; Desmet W
EuroIntervention; 2014 Aug; 10(4):439-48. PubMed ID: 25138182
[TBL] [Abstract][Full Text] [Related]
18. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty.
Oh PC; Suh SY; Kang WC; Lee K; Han SH; Ahn T; Shin EK
Korean J Intern Med; 2016 May; 31(3):501-6. PubMed ID: 26951915
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
Almalla M; Schröder J; Pross V; Marx N; Hoffmann R
Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]